This inventor holds 1 USPTO granted patent and 5 published patent applications and 1 EPO patent. Top assignee: Orion Corporation. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Josef Messinger: Innovator in Pharmaceutical Compounds
Introduction
Josef Messinger is a notable inventor based in Espoo, Finland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit catechol O-methyltransferase (COMT) activity. His work has implications for various therapeutic applications.
Latest Patents
Messinger holds a patent for "Catechol O-methyltransferase activity inhibiting compounds." The compounds of formula (I), as defined in the claims, exhibit COMT enzyme inhibiting activity and are thus useful as COMT inhibitors. The patent also discloses methods of treatment and pharmaceutical dosage forms.
Career Highlights
Josef Messinger is associated with Orion Corporation, a prominent company in the pharmaceutical industry. His work at Orion has allowed him to focus on innovative solutions that address medical needs through advanced research and development.
Collaborations
Throughout his career, Messinger has collaborated with talented individuals such as Taina Pajunen and Matti Vaismaa. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Josef Messinger's contributions to the field of pharmaceuticals, particularly through his patent on COMT inhibitors, highlight his role as an innovator. His work continues to influence the development of effective treatments in medicine.